← Back to All Filings

Lilly Endowment Sells $16.4M in Eli Lilly (LLY) Stock

Low SignificanceNovember 12, 2025 at 4:02:53 PM EST

ELI LILLY & Co

$LLY4CIK: 0000059478

Subscribe to track LLY

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Lilly Endowment Sells $16.4M in Eli Lilly (LLY) Stock

Company: ELI LILLY & Co (LLY) Form: 4 | Filed: 2025-11-12 Significance: Low

Insider: LILLY ENDOWMENT INC Title: null | Relationship: 10% Owner

Transaction: • Type: Sale • Shares: 16,869 • Price: ~$972.53 (VWAP) • Value: $16,405,642 • Owned After: 93,695,109

Key Insight: Despite the large dollar value, this sale represents a minuscule fraction (<0.02%) of the Endowment's total holdings and is immaterial relative to the company's market cap.

Market Context: This appears to be a routine diversification or liquidity-raising sale by the foundational shareholder, not a change in strategic outlook.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: ELI LILLY & Co (LLY)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Lilly Endowment Inc., a 10% owner, executed a minor sale of its position, representing an insignificant portion of its total holdings and the company's market capitalization.
  • Market Impact: The transaction is too small relative to the insider's stake and the company's size to have a meaningful market impact.

Company Information

FieldValue
CompanyELI LILLY & Co
Ticker SymbolLLY
CIK0000059478
IndustryPHARMACEUTICAL PREPARATIONS [2834]

Insider Information

FieldValue
NameLILLY ENDOWMENT INC
CIK0000316011
Title/Positionnull
Relationship10% Owner

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-10
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved16,869
Price Per Share~$972.53 (Weighted Average)
Total Value$16,405,642
Shares Owned After93,695,109
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$16,405,642
% of Market Cap0.0019%
Shares Transacted16,869
% of Shares Outstanding0.0018%
Post-Transaction Ownership93,695,109 shares (9.90% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The $16.4 million sale is negligible for a mega-cap company with an $865.16 billion market capitalization.
  • Ownership Concentration: The sale represents a tiny fraction (approximately 0.018%) of the Endowment's substantial stake, which remains at a formidable 9.90% of all outstanding shares post-transaction.
  • Transaction Significance: The transaction's value and share count fall well below the thresholds for moderate or high significance. It is considered a routine portfolio adjustment.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The sale is immaterial in the context of both the insider's total holdings and the company's vast market capitalization. It does not signal a change in the insider's conviction.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The transaction size is a fraction of the stock's typical daily trading volume.
  • Sentiment Indicator: Neutral. This is a routine transaction for a large foundation that periodically sells shares for its operational and philanthropic funding needs.

Additional Context

Transaction Notes

  • Special Circumstances: The sale was executed in multiple transactions at weighted average prices, as detailed in the filing's footnotes. This is standard practice for large block trades to minimize market impact.
Topics:#EliLilly#LLY#InsiderTrading#SECFiling#Form4#InsiderSell#LillyEndowment#StockMarket#Investing#Pharmaceuticals

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.